TAK-676

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-676, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers [Phase 1]